πŸ‡ΊπŸ‡Έ FDA
Patent

US 11028050

Salts and polymorphs of a PDE4 inhibitor

granted A61PA61P25/28

Quick answer

US patent 11028050 (Salts and polymorphs of a PDE4 inhibitor) held by Tetra Discovery Partners expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Tetra Discovery Partners
Grant date
Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P25/28